BACKGROUND: Secretome derived from Wharton’s jelly mesenchymal stem cells (WJ-MSC) has a beneficial effect for ocular surface regeneration; however, the high amount of vascular endothelial growth factor (VEGF) remains a challenge for its application. AIM: The aim of the study was to investigate the effect of resveratrol (RV) (VEGF reducing agent) preconditioned WJ-MSC secretome in Concanavalin A-induced severe dry eye model. METHODS: Pre-and post-experimental study composed of topical instillation of WJ-MSC secretome group, balanced salt solution control group, and normal control group. Tear production, tear break-up time (TBUT), corneal fluorescein dye staining, VEGF level in aqueous tear, goblet cell density, and inflammatory cells in the ocular surface were analyzed. RESULTS: Topical instillation of RV preconditioned WJ-MSC secretome successfully improved tear film production (p = 0.008) and TBUT (p = 0.008), promoted goblet cell restoration (p = 0.023) and reduced corneal fluorescein staining (p = 0.003), while inhibited infiltration of inflammatory cells (p = 0.01) and secretion of VEGF in aqueous tear (p = 0.003). CONCLUSION: Topical instillation of RV preconditioned WJ-MSC secretome has great potential as cell-free based therapy to preserve ocular surface in an experimental model of severe Dry eye disease.

Original languageEnglish
Pages (from-to)1116-1123
Number of pages8
JournalOpen Access Macedonian Journal of Medical Sciences
Issue numberB
Publication statusPublished - 2 Jan 2020


  • Dry eye disease
  • Mesenchymal stem cell
  • Ocular surface
  • Resveratrol
  • Secretome


Dive into the research topics of 'Topical instillation of resveratrol preconditioned wharton’s jelly mesenchymal stem cell secretome preserves ocular surface in experimental model of severe dry eye disease'. Together they form a unique fingerprint.

Cite this